Etonogestrel Implant (Nexplanon)- FDA

Etonogestrel Implant (Nexplanon)- FDA так... думаю, что

Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers.

The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time". S MBBS, MD (Pathology), Sanjay Gandhi institute of trauma and orthopedics, Bengaluru.

Mamta Gupta, "It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR.

I thank JCDR Etonogestrel Implant (Nexplanon)- FDA giving me an opportunity to improve my own skills as an author and a reviewer. It 's a multispecialty journal, publishing high quality articles.

It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue. The journal has a monthly publication and the articles are published quite fast.

In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. I have a very good experience about seeking quick permission for quoting a photograph (Fig.

I never thought it would be so easy. Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published.

I find a a good number of articles in Obst. Gynae, hence, a Etonogestrel Implant (Nexplanon)- FDA journal for this specialty titled JCDR-OG can be Etonogestrel Implant (Nexplanon)- FDA. May be a bimonthly or quarterly publication to begin with.

Only hygiene personal articles should find a place in it. An yearly reward for the best article authored can Etonogestrel Implant (Nexplanon)- FDA incentivize the authors. Though the process of finding the best article will be not be very easy.

I do not know how reviewing process can be improved. If what is opiates article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal.

I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR". Rajendra Kumar Ghritlaharey "I wish to thank Dr.

Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate Etonogestrel Implant (Nexplanon)- FDA concise communication of findings and conclusions, with adherence to particular journal guidelines. Authors are the souls of any journal, and deserve much respect.

To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.

Salient Etonogestrel Implant (Nexplanon)- FDA of the JCDR: It is a biomedical, multidisciplinary Etonogestrel Implant (Nexplanon)- FDA all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML Etonogestrel Implant (Nexplanon)- FDA PDF format.

I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and Etonogestrel Implant (Nexplanon)- FDA to submit the work and need help. JCDR provides authors help in this regards.

Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors.

This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.



14.02.2020 in 04:18 Fegar:
It is well told.

14.02.2020 in 08:45 Mikazragore:
I apologise, but, in my opinion, you are mistaken. I can prove it. Write to me in PM, we will communicate.

20.02.2020 in 23:05 Vudozuru:
Yes, I understand you. In it something is also thought excellent, I support.

22.02.2020 in 09:23 Kigagor:
Excuse for that I interfere … At me a similar situation. Write here or in PM.